Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 11, 2025 • 6:30 AM ET

Date/Time Source News Release
06/03/2025 04:05 PM EDT Business Wire Quince Therapeutics Exceeds 75% Enrollment in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia
05/13/2025 08:00 AM EDT Business Wire Quince Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results
04/30/2025 04:05 PM EDT Business Wire Quince Therapeutics to Present at Citizens Life Sciences Conference
04/03/2025 04:05 PM EDT Business Wire Quince Therapeutics to Present at Jones Healthcare and Technology Innovation Conference
03/24/2025 04:05 PM EDT Business Wire Quince Therapeutics Provides Business Update and Reports Fiscal Year 2024 Financial Results
02/07/2025 08:00 AM EST Business Wire Quince Therapeutics to Host Investor Webinar Today Focused on Addressing the High Unmet Need in Ataxia-Telangiectasia
02/05/2025 04:05 PM EST Business Wire Quince Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
02/04/2025 04:05 PM EST Business Wire Quince Therapeutics Receives Notice of Allowance Covering Innovative Method of Use for Lead Indication Ataxia-Telangiectasia
01/28/2025 08:00 AM EST Business Wire Quince Therapeutics to Host Investor Webinar on February 7, 2025 Focused on Addressing the High Unmet Need in Ataxia-Telangiectasia
01/27/2025 08:00 AM EST Business Wire Quince Therapeutics Announces Frontiers in Neurology Publication of Long-Term Safety of EryDex in Pediatric Patients with Ataxia-Telangiectasia
Page

Additional News

As of June 11, 2025 • 6:30 AM ET

Date/Time Source News Release
05/15/2025 09:50 AM EDT SeekingAlpha Quince Therapeutics: Data In Ataxia-Telangiectasia Scheduled For Early 2026
05/13/2025 08:18 AM EDT SeekingAlpha Quince Therapeutics GAAP EPS of -$0.34
05/12/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, May 12th, 2025
05/12/2025 05:31 AM EDT US Earnings Reports Expected earnings - Quince Therapeutics Inc.
03/24/2025 04:22 PM EDT SeekingAlpha Quince Therapeutics GAAP EPS of -$1.31 misses by $0.11
12/18/2024 04:22 PM EST SeekingAlpha Quince Therapeutics files for $200M mixed securities shelf
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Quince Therapeutics Inc.
11/13/2024 06:02 PM EST SeekingAlpha Quince Therapeutics GAAP EPS of -$0.13 beats by $0.02
10/30/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Wed, Oct 30, 2024 as of 10.00 am ET
10/22/2024 09:15 AM EDT KlickAnalytics Buy Recommendation Issued On QNCX By EF Hutton
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.